Voip-Pal.com Inc. (VPLM)
USD 0.01
(-1.32%)
USD 0.01
(-1.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3 Million | -1.1 Million | -955.55 Thousand | -1.14 Million | -2.67 Million | -2.24 Million |
| Net Income | -23.1 Million | -3.69 Million | -2.15 Million | -2.34 Million | -9.07 Million | -8.4 Million |
| Depreciation & Amortization | 140.45 Thousand | 140.45 Thousand | 140.45 Thousand | 140.45 Thousand | 138.95 Thousand | 138.2 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 20.07 Million | 2.35 Million | 1 Million | 135.47 Thousand | 5.08 Million | 2.55 Million |
| Change in working capital | -139.75 Thousand | -9749.00 | 168.78 Thousand | 387.16 Thousand | 230.57 Thousand | -415.35 Thousand |
| Other non-cash items | 25.24 Thousand | 101.6 Thousand | -109.63 Thousand | 534.5 Thousand | 949.45 Thousand | 3.88 Million |
| Investing Cash Flow | - | - | - | - | -11.91 Thousand | - |
| Investments in PPE | - | - | - | - | -11.91 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.91 Million | 1.23 Million | 1.01 Million | 299.31 Thousand | 471.24 Thousand | 5.4 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.91 Million | 1.23 Million | 1.01 Million | 299.31 Thousand | 219 Thousand | 3.4 Million |
| Other Financing Activities | 4918.60 | 1232.75 | 1018.52 | 299.31 | 252.24 Thousand | 2 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -139.75 Thousand | -9749.00 | 168.78 Thousand | 387.16 Thousand | 230.57 Thousand | -415.35 Thousand |
| Cash at beginning of period | 305.48 Thousand | 176.5 Thousand | 113.53 Thousand | 960.49 Thousand | 3.17 Million | 12.15 Thousand |
| Cash at end of period | 2.21 Million | 305.48 Thousand | 176.5 Thousand | 113.53 Thousand | 960.49 Thousand | 3.17 Million |
| Capital Expenditure | - | - | - | - | -11.91 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.91 Million | 128.98 Thousand | 62.96 Thousand | -846.95 Thousand | -2.21 Million | 3.16 Million |
| Free Cash Flow | -3 Million | -1.1 Million | -955.55 Thousand | -1.14 Million | -2.68 Million | -2.24 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.6 Million | -2.66 Million | -568.86 Thousand | -23.1 Million | -488.79 Thousand | -21.22 Million |
| Depreciation & Amortization | 564.00 | 35.11 Thousand | 35.11 Thousand | 140.45 Thousand | 35.11 Thousand | 35.11 Thousand |
| Deferred income taxes | - | - | -148.09 Thousand | - | -148.08 Thousand | - |
| Stock-based compensation | 2.74 Million | 2 Million | 77.86 Thousand | 20.07 Million | 77.86 Thousand | 19.84 Million |
| Change in working capital | -143.3 Thousand | 169.2 Thousand | 795.00 | -139.75 Thousand | -115.03 Thousand | -122.1 Thousand |
| Other non-cash items | 2.74 Million | 2.23 Million | 173.09 Thousand | 25.24 Thousand | 148.08 Thousand | 62.5 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.52 Million | 632.5 Thousand | 125 Thousand | 4.91 Million | 797 Thousand | 2.14 Million |
| Debt repayment | -125 Thousand | -125 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.54 Million | 757.5 Thousand | 125 Thousand | 4.91 Million | 797 Thousand | 2.14 Million |
| Other Financing Activities | 103 Thousand | 632.5 Thousand | 125 Thousand | 4918.60 | 797.00 | 2149.75 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | -14.12 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -143.3 Thousand | 169.2 Thousand | 14.92 Thousand | -139.75 Thousand | -115.03 Thousand | -122.1 Thousand |
| Cash at beginning of period | 2.24 Million | 1.91 Million | 2.21 Million | 305.48 Thousand | 1.91 Million | 1.16 Million |
| Cash at end of period | 2.76 Million | 2.24 Million | 1.91 Million | 2.21 Million | 2.21 Million | 1.91 Million |
| Capital Expenditure | -4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 522.49 Thousand | 332.5 Thousand | -305.09 Thousand | 1.91 Million | 306.15 Thousand | 744.86 Thousand |
| Free Cash Flow | -998.88 Thousand | -300 Thousand | -430.09 Thousand | -3 Million | -490.84 Thousand | -1.4 Million |
JUBLPHARMA
300220
CTRL
LIO
OXBR
SUPREMEIND